v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
REVENUE $ 1,142 $ 108
COST OF GOODS SOLD 497 0
GROSS PROFIT 645 108
OPERATING EXPENSES:    
Research and development expenses 1,482 1,954
Selling and marketing expenses 800 1,201
General and administration expenses 6,968 6,133
Impairment of assets 251 874
TOTAL OPERATING EXPENSES 9,501 10,162
OPERATING (LOSS) (8,856) (10,054)
OTHER INCOME (EXPENSE)    
Interest and bank fees (159) (69)
Interest income 89 0
Foreign exchange gain (loss) (5) 11
Change in derivative fair value (9,369) (156)
Loss on settlement (1,353) 0
Other (income) expenses (224) (190)
TOTAL OTHER INCOME (EXPENSE) (11,021) (404)
LOSS BEFORE INCOME TAX (19,877) (10,458)
Income tax provision (benefit) 5 (2)
NET LOSS AND COMPREHENSIVE LOSS (19,882) (10,460)
Deemed dividend on warrant inducement 4,649 0
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (24,531) $ (10,460)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (1.97) $ (1.6)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 12,443,435 6,546,769